Integrated Stability Storage and Analytical Testing Services For Global Product Approval

Supporting IND, NDA, 510 (k), BLA, ANDA, and Commercial Programs Across Small Molecules, Peptides, and Biologics

SmaBio Labs provides GMP-compliant stability storage services and pharmaceutical stability testing to support drug substance, drug product and device development across preclinical, clinical, and commercial stages. Our stability studies are designed and executed in accordance with ICH (International Council for Harmonization) guidelines, including Q1A(R2) (drug products), Q1B (photostability), Q1D (bracketing and matrixing), Q1E (evaluation of stability data), and Q5C (biologics), ensuring alignment with current global regulatory expectations.

Stability-storage-capabilities

Stability Storage & Testing Services

Fully qualified stability chambers capable of supporting various ICH climatic zones and standard study conditions for both small molecules and biologics.

Defines recommended storage conditions, testing intervals, and shelf-life determination for pharmaceutical products under controlled environments.

Q1A(R2)

Drug products

Evaluates the effect of light exposure on drug products to ensure stability, efficacy, and safety throughout their lifecycle.

Q1B

Photostability Testing

Uses bracketing and matrixing strategies to safely reduce the number of physical samples required for stability testing.

Q1D

Bracketing and matrixing

Details the statistical evaluation and extrapolation of that data to officially establish a product's shelf life.

Q1E

Evaluation of stability data

Requires highly specialized testing protocols to ensure the structural integrity and activity of sensitive biological products.

Q5C

Biologics

Frozen

Fully qualified stability chambers capable of supporting various ICH climatic zones and standard study conditions for both small molecules and biologics.

Engineered for Reliable  Stability Outcomes

Stability Storage Capabilities

Ensure product quality and shelf-life accuracy with scientifically validated stability studies across a wide range of environmental conditions aligned with global ICH guidelines.

What We Cover

Long-term, intermediate & accelerated conditions
Refrigerated and frozen storage (including biologics)
Photostability & freeze–thaw evaluations

We specialize in handling stability studies for pharmaceutical, biological, and medical device products, ensuring they are maintained under carefully controlled conditions in line with ICH guidelines and FDA regulatory requirements.

Infrastructure & Compliance Systems

Our infrastructure is designed to ensure reliability, regulatory compliance, and uninterrupted operations through advanced monitoring and control systems.

Stability-testing

24/7 environmental monitoring with calibrated probes

Continuous monitoring using calibrated probes to maintain precise environmental conditions.

Alarm systems with defined escalation procedures

Integrated alert mechanisms with clearly defined escalation procedures to ensure rapid response.

Generator Systems

Robust generator support to guarantee uninterrupted operations during power failures.

Electronic data systems compliant with 21 CFR Part 11

Secure and compliant digital data management systems ensuring data integrity, traceability, and regulatory adherence.

Stability Study Management

Analytical Testing

Analytical Testing Capabilities

GMP stability testing uses validated, stability-indicating methods suitable for both drug substances and drug products, including small molecules and biologics.

HPLC/UPLC analysis for assay and impurity profiling

Dissolution testing for drug products

Custom dissolution for drug-device combination products

Forced degradation studies to establish stability-indicating methods (ICH Q1A(R2))

Physicochemical characterization (pH, osmolality, viscosity, appearance)

Container closure compatibility studies

Extractables & Leachable Studies

fac

Quality & Regulatory Compliance

SmaBio Labs operates under a robust quality system supporting GMP stability studies across global markets. Our operations align with

Quality & Regulatory Compliance

U.S. Food and Drug Administration (21 CFR Parts 210, 211, and 11)

European Medicines Agency guidelines

ICH quality guidelines (Q1–Q14 series, including Q1A(R2) and Q5C)

Core quality features include

Data integrity practices (ALCOA+)

Audit trails and secure electronic records

Deviation, CAPA, and change control systems

Inspection readiness and internal audit programs

Method development, transfer, and validation are performed in accordance with ICH Q2(R2) and current regulatory expectations.

app

Applications

Our pharmaceutical stability testing services support

Drug substances (APIs) and drug products (ICH Q1A(R2))

Post-approval stability commitments

Biologics and biosimilars (proteins, peptides, monoclonal antibodies) per ICH Q5C

Global registration programs requiring multi-zone (I–IVb) stability data

Clinical trial materials (Phase I–III)

Packaging and container closure system evaluations

SmaBio Labs approach to stability testing integrates ICH stability zones, stability-indicating analytical methods, and risk-based study design. This ensures that stability data generated at SmaBio Labs supports global regulatory submissions and long-term product lifecycle management for both small molecules and biologics.